Dejan Vidovic

471 total citations
15 papers, 341 citations indexed

About

Dejan Vidovic is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Dejan Vidovic has authored 15 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Dejan Vidovic's work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and Retinoids in leukemia and cellular processes (3 papers). Dejan Vidovic is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and Retinoids in leukemia and cellular processes (3 papers). Dejan Vidovic collaborates with scholars based in Canada and Sweden. Dejan Vidovic's co-authors include Paola Marcato, Mohammad Sultan, Krysta M. Coyle, Shashi Gujar, Cheryl A. Dean, Margaret L. Thomas, Brianne M. Cruickshank, Carman A. Giacomantonio, Prathyusha Konda and Ian C.G. Weaver and has published in prestigious journals such as Scientific Reports, Annals of Oncology and Cell Death and Differentiation.

In The Last Decade

Dejan Vidovic

13 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dejan Vidovic Canada 8 226 143 142 76 28 15 341
Małgorzata Krześniak Poland 11 237 1.0× 108 0.8× 89 0.6× 40 0.5× 35 1.3× 23 325
Yee Peng Phoon United States 9 150 0.7× 128 0.9× 60 0.4× 120 1.6× 21 0.8× 21 318
Kanwal Minhas Canada 8 209 0.9× 56 0.4× 135 1.0× 78 1.0× 22 0.8× 13 344
Mallika Ramakrishnan Germany 8 134 0.6× 134 0.9× 79 0.6× 80 1.1× 25 0.9× 8 299
Herta Bettendorf Germany 12 217 1.0× 92 0.6× 68 0.5× 84 1.1× 23 0.8× 15 387
Xiaojian Zhu China 12 219 1.0× 76 0.5× 146 1.0× 35 0.5× 70 2.5× 30 356
Enilze M.S.F. Ribeiro Brazil 10 208 0.9× 56 0.4× 141 1.0× 37 0.5× 25 0.9× 22 303
Wei-Chao Hao China 9 216 1.0× 74 0.5× 156 1.1× 74 1.0× 16 0.6× 12 348
Mayinuer Maitituoheti United States 8 247 1.1× 75 0.5× 83 0.6× 51 0.7× 31 1.1× 12 352
Shoua Yang United States 8 127 0.6× 78 0.5× 63 0.4× 137 1.8× 17 0.6× 9 258

Countries citing papers authored by Dejan Vidovic

Since Specialization
Citations

This map shows the geographic impact of Dejan Vidovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dejan Vidovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dejan Vidovic more than expected).

Fields of papers citing papers by Dejan Vidovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dejan Vidovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dejan Vidovic. The network helps show where Dejan Vidovic may publish in the future.

Co-authorship network of co-authors of Dejan Vidovic

This figure shows the co-authorship network connecting the top 25 collaborators of Dejan Vidovic. A scholar is included among the top collaborators of Dejan Vidovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dejan Vidovic. Dejan Vidovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
3.
Vidovic, Dejan, Lucy Helyer, Sylvia Pasternak, & Carman A. Giacomantonio. (2023). Abscopal responses in patients with metastatic melanoma involving skin and subcutaneous tissues treated with intralesional IL2 plus BCG. Frontiers in Oncology. 13. 1160269–1160269. 4 indexed citations
4.
Vidovic, Dejan, et al.. (2022). Cutaneous Breast Cancer Metastasis Is Effectively Treated With Intralesional Interleukin-2 and Imiquimod: A Case Report and Brief Literature Review. Frontiers in Oncology. 12. 877014–877014. 4 indexed citations
5.
Sultan, Mohammad, Jacob T. Nearing, Justin M. Brown, et al.. (2021). An in vivo genome‐wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer. Molecular Oncology. 15(8). 2046–2064. 7 indexed citations
6.
Cruickshank, Brianne M., Justin M. Brown, Wasundara Fernando, et al.. (2021). LncRNA PART1 Promotes Proliferation and Migration, Is Associated with Cancer Stem Cells, and Alters the miRNA Landscape in Triple-Negative Breast Cancer. Cancers. 13(11). 2644–2644. 17 indexed citations
7.
8.
Vidovic, Dejan & Carman A. Giacomantonio. (2020). Insights into the Molecular Mechanisms Behind Intralesional Immunotherapies for Advanced Melanoma. Cancers. 12(5). 1321–1321. 13 indexed citations
9.
Sultan, Mohammad, Dejan Vidovic, Cheryl A. Dean, et al.. (2019). Retinoic acid and arsenic trioxide induce lasting differentiation and demethylation of target genes in APL cells. Scientific Reports. 9(1). 9414–9414. 29 indexed citations
10.
Cruickshank, Brianne M., et al.. (2019). Long non-coding RNA PART1 contributes to cell proliferation and stem cell maintenance in triple-negative breast cancer. Annals of Oncology. 30. iii22–iii22. 1 indexed citations
11.
Vidovic, Dejan, Prathyusha Konda, Cheryl A. Dean, et al.. (2019). ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells. Cell Death and Differentiation. 27(1). 363–378. 91 indexed citations
12.
Coyle, Krysta M., Cheryl A. Dean, Margaret L. Thomas, et al.. (2018). DNA Methylation Predicts the Response of Triple-Negative Breast Cancers to All-Trans Retinoic Acid. Cancers. 10(11). 397–397. 22 indexed citations
13.
Sultan, Mohammad, Dejan Vidovic, Krysta M. Coyle, et al.. (2018). Epigenetic Silencing of TAP1 in Aldefluor+ Breast Cancer Stem Cells Contributes to Their Enhanced Immune Evasion. Stem Cells. 36(5). 641–654. 47 indexed citations
14.
Sultan, Mohammad, Krysta M. Coyle, Dejan Vidovic, et al.. (2016). Hide-and-seek: the interplay between cancer stem cells and the immune system. Carcinogenesis. 38(2). 107–118. 74 indexed citations
15.
Coyle, Krysta M., J. Patrick Murphy, Dejan Vidovic, et al.. (2016). Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1. Oncotarget. 7(28). 44096–44112. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Małgorzata Krześniak Breakdown of academic impact, for papers by Yee Peng Phoon Breakdown of academic impact, for papers by Kanwal Minhas Breakdown of academic impact, for papers by Mallika Ramakrishnan Breakdown of academic impact, for papers by Herta Bettendorf Breakdown of academic impact, for papers by Xiaojian Zhu Breakdown of academic impact, for papers by Enilze M.S.F. Ribeiro Breakdown of academic impact, for papers by Wei-Chao Hao Breakdown of academic impact, for papers by Mayinuer Maitituoheti Breakdown of academic impact, for papers by Shoua Yang
Rankless by CCL
2026